One study found that after 10 years, IgA nephropathy came back in 19% of those who had a kidney transplant. About 4 out of 10 (40%) transplanted kidneys in people with IgA nephrology eventually fail.

EP: 3. Pathogenesis of IgA Nephropathy: The 4-Hit Cascade, A Proliferation-Inducing Ligand (APRIL), and cytokines EP: 4. Diagnosing IgA Nephropathy EP: 5. Signs and Symptoms of IgA Nephropathy EP: 6.

For more information about IgA nephropathy and the role of APRIL, consider signing up to receive additional news and insights about IgA nephropathy at igancascade.com. October 2024 21US24EUP0096 ...

EP: 3. Pathogenesis of IgA Nephropathy: The 4-Hit Cascade, A Proliferation-Inducing Ligand (APRIL), and cytokines EP: 4. Diagnosing IgA Nephropathy EP: 5. Signs and Symptoms of IgA Nephropathy EP: 6.

IgA nephropathy can be challenging, but a support system makes it easier to manage. Learn how to take steps to stay connected to your community when dealing with this disease.

Cite this: Looking Back at an Early Patient Encounter and the Changing Treatment Landscape in IgA Nephropathy - Medscape - March 05, 2025.

Biogen (($CC:HTER)) announced an update on their ongoing clinical study. Biogen Inc. (BIIB) has announced an update on its ...

In this video, Ali Poyan Mehr, MD, Regional Director of the Glomerular Disease Program at Kaiser Permanente Northern California, discusses the major risk factors for IgA nephropathy.

DelveInsight's " IgA Nephropathy Market Insight, Epidemiology And Market Forecast - 2034 " report provides an extensive analysis of IgA nephropathy (IgAN), including historical and forecasted ...

NephCure, a nonprofit organization focused on rare, protein-spilling kidney diseases, announced IgA Nephropathy Awareness Day, Sept. 26, to promote early diagnosis and treatment of the disease ...

Secondary Source The Lancet Source Reference: Lundberg S and Bergen K "We can go further in non-immunosuppressive treatment of IgA nephropathy" Lancet 2023; DOI: 10.1016/S0140-6736 (23)00630-X.

Pietro A. Canetta, MD, recounts how, as a young nephrologist at Columbia University, he was encouraged by a mentor to give a talk on IgA nephropathy, a topic that at the time had limited research ...